Vertex Growth

Vertex Growth is the dedicated growth-stage fund within the Vertex Holdings network (Temasek-affiliated), headquartered in Singapore and deploying $5M-$25M cheques at Series B, Series C, and growth into proven digital health platforms across Asia, including AI/ML in healthcare. The firm benefits from cross-fund pipeline access through Vertex’s earlier-stage SEA, Israel, China, and US franchises, which generates proprietary deal flow and meaningful conviction signal at growth. For founders, Vertex Growth is best positioned as a regional growth lead for Series B-ready digital health and AI platforms with multi-country traction across Singapore, Indonesia, India, Vietnam, and increasingly Japan and Korea. The right founder profile is an Asia-focused operator with $10M+ ARR, durable retention, and credible international expansion signals. Pre-Series B founders, single-country plays, asset-heavy clinic chains, and consumer wellness brands should not approach. The cleanest entry path is via a Vertex Holdings portfolio CEO from the SEA or Israel franchises, a Vertex Growth-affiliated banker or strategic adviser, or warm introductions from international growth-stage funds that frequently co-invest. In the pitch, lead with rule-of-40 metrics, ARR, gross retention by cohort, sales productivity, and a credible plan for category expansion or international growth into Japan, Korea, or US markets where relevant. Caveats: Vertex Growth runs an institutional process with deep reference checks and expects active board engagement. AI focus is real but commercial; partners will probe model claims through enterprise adoption rather than benchmark performance. Cycle times are months and term sheets carry institutional governance provisions. Confirm reserves and follow-on policy explicitly given the firm’s preference for concentrated positions across the lifecycle.